Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual J.P. Morgan healthcare conference on Monday, January 12, 2026.

The FDA designated the recall of certain Medtronic Bravo esophageal pH monitoring capsules as class I, the most serious type.

Supermodels, singers, and diabetics are all wearing it. Jake Leach, Dexcom CEO, says these sensors are the future.

Wearable health devices may soon operate under looser regulatory oversight following new guidance from the FDA ...

The global pulse oximeter market size was valued at USD 3.56 billion in 2024 and is predicted to hit around USD 6.76 billion by 2034, rising at a 6.64% CAGR, a study published by Towards Healthcare a ...

It has issued new guidance to clarify its regulatory approach on wearable devices. Read more at straitstimes.com. Read more ...

The global diabetes injection pens market is projected to grow at a CAGR of approximately 7% through 2028. Market expansion ...

These technologies are improving all the time. If they’re not making claims that they are medical grade, let’s let the market ...

The global Surgical Retractors Market is projected to grow at a CAGR of approximately 6–7% during the forecast period. Market ...

Capnography is a medical monitoring device capable of non-invasively measuring partial CO2 levels by plotting a capnograph on the x and y-axis. These devices are categorized as mainstream, microstream ...

FDA plans limited regulation of wearable medical devices, boosting Apple, Fitbit, Oura stocks as 50% of Americans use fitness ...

The market is segmented into pressure sensors, temperature sensors, blood glucose sensors, blood oxygen sensors, electrocardiogram (ECG) sensors, image sensors, and others. Pressure sensors dominate ...